AmCad BioMed
Brief
AmCad BioMed is a pioneer in AI-driven Computer-Assisted Detection and Diagnosis (CAD) devices, offering innovative solutions for early disease detection and diagnosis, including thyroid cancer, sleep apnea, and liver conditions.
Profile
Founded in 2008, AmCad's mission is to help medical professionals make efficient and accurate diagnoses by supporting detailed sonographic visualisation and quantification.
By integrating AI technology with clinician expertise, AmCad will continue to pioneer best-in-class imaging solutions that anticipate mainstream medical needs.
Our extensive expertise, from R&D to commercialisation, has resulted in the world's first FDA-cleared ultrasound Computer-Assisted Detection (CAD) devices.
Headquarters